Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE)

Citation
I. Wichmann et al., Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE), CLIN EXP IM, 119(3), 2000, pp. 530-532
Citations number
10
Categorie Soggetti
Immunology
Journal title
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
ISSN journal
00099104 → ACNP
Volume
119
Issue
3
Year of publication
2000
Pages
530 - 532
Database
ISI
SICI code
0009-9104(200003)119:3<530:ATDOIS>2.0.ZU;2-7
Abstract
Autoantibodies against the transcriptional DEK protein have been considered characteristic of the pauciarticular onset subtype of juvenile rheumatoid arthritis (JRA) associated with iridocyclitis in young girls. In this study we investigated the presence of anti-DEK autoantibodies in the sera of 288 patients with SLE using a recombinant DEK protein as autoantigenic target. Thirty sera (10.4%) were positive against DEK protein by immunoblotting. P atients with anti-DEK autoantibodies show a lower frequency of cutaneous ma nifestation, exhibit more frequently certain markers of a chronic inflammat ory status like anaemia and positivity for C-reactive protein, as well as a higher frequency of anti-double-stranded DNA autoantibodies. In contrast t o JRA patients positive for anti-DEK autoantibodies, no association with er osive arthritis nor iridocyclitis were found in SLE. In conclusion, our res ults show that 10.4% of SLE patients from our area show antibodies against DEK protein, although this feature did not clearly establish a clinical sub set of the disease.